Literature DB >> 25205714

miR-126 regulates platelet-derived growth factor receptor-α expression and migration of primary human osteoblasts.

Yvonne Schmidt, Filip Simunovic, Sandra Strassburg, Dietmar Pfeifer, G Björn Stark, Günter Finkenzeller.   

Abstract

Adequate vascularization is an essential requirement for bone development, fracture healing and bone tissue engineering. We have previously described the coculture of primary human osteoblasts (hOBs) and human endothelial cells (HUVECs), designed to investigate the interactions between these cells. In this system, we showed that cocultivation of these two cell types leads to a downregulation of platelet-derived growth factor receptor-α (PDGFR-α) in hOBs, which was a consequence of reduced mRNA stability. In the current study we investigated the possible involvement of microRNAs in this process. Firstly, we performed a microarray analysis of osteoblastic miRNAs following cocultivation with HUVECs, revealing an upregulation of miR-126. This result was confirmed by RT-qPCR, and we observed that the increase is dependent on direct cell-to-cell contacts. Gain-of-function and loss-of-function experiments showed that miR-126 is a negative regulator of PDGFR-α mRNA. Additionally, migration of hOBs was inhibited by miR-126 overexpression and stimulated by miR-126 inhibition. Addition of PDGFR-α blocking antibody to hOB culture also inhibited hOB migration. There was no effect of miR-126 modulation on osteoblast proliferation, apoptosis rate or differentiation. In conclusion, we report that the miR-126/PDGFR-α system regulates the migratory behavior of human osteoblasts, without exerting effects on cell survival and differentiation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25205714     DOI: 10.1515/hsz-2014-0168

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  8 in total

Review 1.  Osteoblast migration in vertebrate bone.

Authors:  Antonia Thiel; Marie K Reumann; Adele Boskey; Johannes Wischmann; Rüdiger von Eisenhart-Rothe; Philipp Mayer-Kuckuk
Journal:  Biol Rev Camb Philos Soc       Date:  2017-06-19

2.  miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.

Authors:  Hong-Bo Zhang; Li-Chao Sun; Lan Ling; Lu-Hong Cong; Rui Lian
Journal:  Exp Ther Med       Date:  2016-07-27       Impact factor: 2.447

Review 3.  MicroRNAs in bone diseases.

Authors:  L Gennari; S Bianciardi; D Merlotti
Journal:  Osteoporos Int       Date:  2016-11-30       Impact factor: 4.507

4.  microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.

Authors:  Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  [The regulatory role of microRNA in osteogenic differentiation of mesenchymal stem cells and its application as a therapeutic target and diagnostic tool in orthopedic diseases].

Authors:  Xiaolong Li; Qingquan Kong
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-10-15

Review 6.  A meta-analysis: microRNAs' prognostic function in patients with nonsmall cell lung cancer.

Authors:  Na Yu; Qingjun Zhang; Qing Liu; Jiayu Yang; Sheng Zhang
Journal:  Cancer Med       Date:  2017-08-15       Impact factor: 4.452

Review 7.  Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.

Authors:  Kwaku Appiah-Kubi; Ying Wang; Hai Qian; Min Wu; Xiaoyuan Yao; Yan Wu; Yongchang Chen
Journal:  Tumour Biol       Date:  2016-05-19

8.  Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.

Authors:  Kazuki Heishima; Travis Meuten; Kyoko Yoshida; Takashi Mori; Douglas H Thamm
Journal:  BMC Vet Res       Date:  2019-01-25       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.